Trials / Completed
CompletedNCT00213512
Effect of Anti CD20 in Pemphigus Desease
Traitment of Patients Presenting Pemphigus With Anti CD20 (Mabthera).
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 22 (planned)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
to treat in an open non comparative clinical study patients presenting pemphigus with corticodependance, corticoresistance and contre-indication to systemic steroids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mabthera |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2006-06-01
- Completion
- 2008-10-01
- First posted
- 2005-09-21
- Last updated
- 2013-06-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00213512. Inclusion in this directory is not an endorsement.